← Leaderboards
Guofang Zhang
Coriell Institute For Medical Research
$1,394,926
Attributed
$2,789,852
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $825.3K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,789,852 · 2
By mechanism
R01$2,359,087 · 1
R21$430,765 · 1
Top collaborators
- Xiaoxin Chen6 shared
Others in their field
Other Rising Stars on “Acetates”
- Susie Dai · Texas A&M Agrilife Research$3,134,186
- Nicholas Collins · Weill Medical Coll Of Cornell Univ$1,536,027
- Monika Joshi · Pennsylvania State Univ Hershey Med Ctr$1,466,430
- Wenchao Qu · State University New York Stony Brook$1,416,275
- Grace Marie Jones · Touro University Of California$1,237,284
- Cesaltina Ferreira Lorenzoni · University Of Tx Md Anderson Can Ctr$1,227,195
Research focus
AcetatesHistone AcetylationLipidsTissuesCellsIn VitroGenetic TranscriptionIn VivoMetabolismPhenotypeDietPathologyMetabolicAcetyl Coenzyme AFutureGenesAutoradiographyAnimal ModelDoseDesignDensityDrug Metabolic DetoxicationCitric Acid CycleAlcohols
Grant awards (6)
NRF2-ACSS2 Axis in Alcohol-induced Metabolic Reprogramming and Esophageal Pathology$579,108
R01 · FY2025 · AA
Triacetin Treatment for Propionic Acidemia by Rebalancing the Acetyl-CoA/Propionyl-CoA Metabolism$246,148
R21 · FY2025 · TR · contact PI
NRF2-ACSS2 Axis in Alcohol-induced Metabolic Reprogramming and Esophageal Pathology$589,786
R01 · FY2024 · AA
Triacetin Treatment for Propionic Acidemia by Rebalancing the Acetyl-CoA/Propionyl-CoA Metabolism$184,617
R21 · FY2024 · TR · contact PI
NRF2-ACSS2 Axis in Alcohol-induced Metabolic Reprogramming and Esophageal Pathology$616,892
R01 · FY2023 · AA
NRF2-ACSS2 Axis in Alcohol-induced Metabolic Reprogramming and Esophageal Pathology$573,301
R01 · FY2022 · AA